Welcome to our dedicated page for Horizon Space Acquisition II Ordinary share news (Ticker: HSPT), a resource for investors and traders seeking the latest updates and insights on Horizon Space Acquisition II Ordinary share stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Horizon Space Acquisition II Ordinary share's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Horizon Space Acquisition II Ordinary share's position in the market.
Horizon Space Acquisition II Corp. (NASDAQ: HSPT) has announced that starting February 5, 2025, holders of the 5,750,000 units sold in its initial public offering can begin separately trading the ordinary shares and rights included in the Units. The Units, which include those sold during the full exercise of the underwriters' over-allotment option, will continue trading on NASDAQ under 'HSPTU,' while separated ordinary shares and rights will trade under 'HSPT' and 'HSPTR' respectively.
Unit holders must contact their brokers and the company's transfer agent, VStock Transfer , to separate their units. The initial public offering was underwritten by Maxim Group , following an SEC-approved registration statement (File No. 333-282758) effective November 12, 2024. The offering was conducted solely through a prospectus available through Maxim Group or the SEC's EDGAR system.